TD Cowen lowered the firm’s price target on Acadia Healthcare (ACHC) to $70 from $91 and keeps a Buy rating on the shares. The firm noted the company issued revised 2024 guidance given disruptions in referral volumes related to recent newsflow and legal inquiries.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $45 from $75 at Deutsche Bank
- Acadia Healthcare Reports Strong Q3 2024 Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Acadia Healthcare cuts FY24 EPS view to $3.35-$3.45 from $3.45-$3.65
- Acadia Healthcare reports Q3 adjusted EPS 91c, consensus 90c